Herbalife Ltd. announced its preliminary financial results for the first quarter of 2026. Net sales grew 7.5-8% year-over-year, which exceeded the high end of the company’s previously issued first quarter guidance. This net sales performance was driven by the Asia Pacific market, with Latin America and Mexico also reporting year-over-year net sales growth.

Zinzino AB reported its preliminary sales results for the first quarter of 2026. Group revenue in the first quarter reached $96.8 million, a 26% year-over-year increase, while the Faun Pharma external sales division fell from approximately $751,000 to approximately $698,000.

Amway announced its financial results for 2025. Sales in 2025 were $7.3 billion. The company stated that “while sales were modestly lower than the previous year, the company advanced key priorities across the business, with many markets and product launches outperforming forecasts and building positive traction heading into 2026.”

The company recorded a net income for the second consecutive quarter and experienced a positive adjusted EBITDA for the ninth consecutive quarter. The company generated positive free cash flow with $39 million in cash on its balance sheet and said it is now preparing for the next phase of its growth strategy.

Nature’s Sunshine announced its financial results for the fourth quarter and full-year 2025. Fourth quarter net sales were up 4.7% year-over-year to $123.8 million with an adjusted EBITDA of $11.9 million, a 16% increase from the same quarter of 2024.

The Real Brokerage, Inc. reported its financial results for the fourth quarter and full-year 2025. Revenue during the fourth quarter increased 44% year-over-year to $505.1 million with a gross profit of $39 million. Adjusted EBITDA during the quarter was $14.2 million, compared to $9.1 million in the same quarter of 2024. Cash provided by operating activities during this period was $149,000.